Takuma Onoe

546 total citations
19 papers, 236 citations indexed

About

Takuma Onoe is a scholar working on Oncology, Otorhinolaryngology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Takuma Onoe has authored 19 papers receiving a total of 236 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Otorhinolaryngology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Takuma Onoe's work include Head and Neck Cancer Studies (10 papers), Lung Cancer Treatments and Mutations (5 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Takuma Onoe is often cited by papers focused on Head and Neck Cancer Studies (10 papers), Lung Cancer Treatments and Mutations (5 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Takuma Onoe collaborates with scholars based in Japan and United States. Takuma Onoe's co-authors include Makoto Tahara, Naomi Kiyota, Koji Matsumoto, Tomoya Yokota, Shunji Takahashi, Akihiro Homma, Jun Taguchi, Katsunari Yane, Hiroki Hara and Takeharu Yamanaka and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Cancer Science.

In The Last Decade

Takuma Onoe

16 papers receiving 232 citations

Peers

Takuma Onoe

ONCOL

PRM

OTORH

SURGE

Anke Van Lierop Germany

Priyanka Bhateja United States

Maria Lucia Iacovino Italy

Jeffery Houghton United States

Michael Wittlinger Germany

Gábor Pajkos Hungary

Grégoire Marret France

Marc Lucas Ooft Netherlands

Angélique Robin France

Cornedine J. de Gooijer Netherlands

Anke Van Lierop Germany

Takuma Onoe

146 ×1.0

ONCOL

43 ×0.5

PRM

47 ×0.6

OTORH

89 ×1.5

29 ×0.7

SURGE

Citations per year, relative to Takuma Onoe Takuma Onoe (= 1×) peers Anke Van Lierop

Countries citing papers authored by Takuma Onoe

Since Specialization

Citations

This map shows the geographic impact of Takuma Onoe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takuma Onoe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takuma Onoe more than expected).

Fields of papers citing papers by Takuma Onoe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takuma Onoe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takuma Onoe. The network helps show where Takuma Onoe may publish in the future.

Co-authorship network of co-authors of Takuma Onoe

This figure shows the co-authorship network connecting the top 25 collaborators of Takuma Onoe. A scholar is included among the top collaborators of Takuma Onoe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takuma Onoe. Takuma Onoe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Yasuda, Kôichi, Kazuto Matsuura, Yoshitaka Honma, et al.. (2025). Indications for chemoradiotherapy in older patients with locally advanced head and neck cancer in Japan: a questionnaire survey in the JCOG head and neck cancer study group. Frontiers in Oncology. 14. 1441056–1441056.

Sakai, Hideki, et al.. (2025). Optimal Sunitinib Dosing Based on Platelet Count in an Older Patient With Gastrointestinal Stromal Tumor. In Vivo. 39(6). 3674–3682.

Koyama, Takashi, Naomi Kiyota, Shogen Boku, et al.. (2024). A phase II trial of paclitaxel plus biweekly cetuximab for patients with recurrent or metastatic head and neck cancer previously treated with both platinum-based chemotherapy and anti-PD-1 antibody. ESMO Open. 9(6). 103476–103476. 10 indexed citations

Tanizaki, Junko, Kan Yonemori, Yasuo Takiguchi, et al.. (2024). 225P Nivolumab for cancer of unknown primary (CUP): Clinical efficacy and biomarker analysis from NivoCUP2 expanded access program (WJOG14620M). Annals of Oncology. 35. S305–S306. 1 indexed citations

Kiyota, Naomi, Yoshinori Imamura, Shogen Boku, et al.. (2023). A phase II trial of paclitaxel plus biweekly cetuximab for patients with recurrent or metastatic head and neck cancer previously treated with both platinum-based chemotherapy and anti-PD-1 antibody.. Journal of Clinical Oncology. 41(16_suppl). 6032–6032. 1 indexed citations

Nagatani, Yoshiaki, Naomi Kiyota, Tomoko Yamazaki, et al.. (2023). A phase II trial of nivolumab for patients with platinum-refractory recurrent or metastatic salivary gland cancer.. Journal of Clinical Oncology. 41(16_suppl). 6092–6092. 4 indexed citations

Saito, Yuki, Akihiro Homma, Naomi Kiyota, et al.. (2022). Human papillomavirus-related oropharyngeal carcinoma. Japanese Journal of Clinical Oncology. 52(7). 700–706. 2 indexed citations

Sakai, Hideki, Takuma Onoe, Shogen Boku, et al.. (2021). 4-step, 2-h carboplatin desensitization in Japanese patients with ovarian cancer: a prospective study. International Journal of Clinical Oncology. 26(8). 1553–1560. 6 indexed citations

Yokota, Tomoya, Akihiro Homma, Naomi Kiyota, et al.. (2020). Immunotherapy for squamous cell carcinoma of the head and neck. Japanese Journal of Clinical Oncology. 50(10). 1089–1096. 42 indexed citations

10.

Takahashi, Tsuyoshi, Toshirou Nishida, Toshihiro Kudo, et al.. (2020). Regorafenib as second-line therapy for imatinib-resistant gastrointestinal stromal tumor (GIST).. Journal of Clinical Oncology. 38(4_suppl). 823–823. 2 indexed citations

11.

Okano, Susumu, Tomohiro Enokida, Takuma Onoe, et al.. (2019). Induction TPF chemotherapy followed by CRT with fractionated administration of cisplatin in patients with unresectable locally advanced head and neck cancer. International Journal of Clinical Oncology. 24(7). 789–797. 14 indexed citations

12.

Onoe, Takuma, Hideki Sakai, Sayuri Watanabe, et al.. (2019). Safety and Relative Dose Intensity of Dose-dense Doxorubicin and Cyclophosphamide Followed by Dose-dense Paclitaxel. Anticancer Research. 39(8). 4379–4383. 2 indexed citations

13.

Naito, Yoichi, Toshihiko Doi, Tsuyoshi Takahashi, et al.. (2019). Regorafenib as second line therapy for imatinib-resistant gastrointestinal stromal tumor (GIST): A phase II study. Annals of Oncology. 30. vi88–vi88. 1 indexed citations

14.

Matsumoto, Koji, et al.. (2019). PARP inhibitors for BRCA wild type ovarian cancer; gene alterations, homologous recombination deficiency and combination therapy. Japanese Journal of Clinical Oncology. 49(8). 703–707. 22 indexed citations

15.

Tahara, Makoto, Naomi Kiyota, Tomoya Yokota, et al.. (2018). Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02). Annals of Oncology. 29(4). 1004–1009. 65 indexed citations

16.

Nishikawa, Tadaaki, Koji Matsumoto, Kenji Tamura, et al.. (2017). Phase 1 dose‐escalation study of single‐agent veliparib in Japanese patients with advanced solid tumors. Cancer Science. 108(9). 1834–1842. 23 indexed citations

17.

Tahara, Makoto, Naomi Kiyota, Tomoya Yokota, et al.. (2016). Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02).. Journal of Clinical Oncology. 34(15_suppl). 6026–6026. 17 indexed citations

18.

Matsumoto, Koji, Takuma Onoe, Akihito Kitao, et al.. (2014). 4-step 4-h carboplatin desensitization protocol for patients with gynecological malignancies showing platinum hypersensitivity: a retrospective study. International Journal of Clinical Oncology. 20(3). 566–573. 24 indexed citations

19.

Onoe, Takuma, et al.. (2014). Initial Treatment for Nasopharyngeal Carcinoma: a Single Center, Retrospective Study. Annals of Oncology. 25. v77–v77.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact